Literature DB >> 15043004

Coverage and costs of mass immunization of an oral cholera vaccine in Vietnam.

Dinh Thiem Vu1, M Moshaddeque Hossain, Dinh Son Nguyen, Thai Hoa Nguyen, Malla R Rao, Gia Canh Do, Abdollah Naficy, Thi Ke Nguyen, Camilo J Acosta, Jacqueline L Deen, John D Clemens, Duc Trach Dang.   

Abstract

The objective of this study was to describe a mass-immunization campaign of a locally-produced oral, killed whole-cell cholera vaccine in Hue city, Vietnam. Mass immunization with a 2-dose regimen of the vaccine was conducted in 13 communes in early 1998. The total, age- and sex-specific vaccine coverage was calculated using data from the vaccination records and the government census. The number of vaccine doses procured, administered, wasted, and left over, and the human and other resources required to prepare and conduct the vaccination campaign were systematically recorded. Government expenditure for planning, procurement, and delivery of the vaccine were documented. In total, 118,555 (79%) of the 49,557 targeted population were fully vaccinated during the mass-vaccination campaign. The total expenditure for the project was US dollar 105,447, resulting in a cost per fully-vaccinated person of US dollar 0.89. Mass immunization with this locally-produced oral, killed cholera vaccine was found to be feasible and affordable with attainment of high vaccination coverage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15043004

Source DB:  PubMed          Journal:  J Health Popul Nutr        ISSN: 1606-0997            Impact factor:   2.000


  25 in total

Review 1.  New-generation vaccines against cholera.

Authors:  John Clemens; Sunheang Shin; Dipika Sur; G Balakrish Nair; Jan Holmgren
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-08       Impact factor: 46.802

2.  Social and cultural determinants of oral cholera vaccine uptake in Zanzibar.

Authors:  Christian Schaetti; Said M Ali; Raymond Hutubessy; Ahmed M Khatib; Claire-Lise Chaignat; Mitchell G Weiss
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

3.  Product Development Partnerships: Case studies of a new mechanism for health technology innovation.

Authors:  Richard T Mahoney
Journal:  Health Res Policy Syst       Date:  2011-08-26

4.  Guinea pig complement potently measures vibriocidal activity of human antibodies in response to cholera vaccines.

Authors:  Kyoung Whun Kim; Soyoung Jeong; Ki Bum Ahn; Jae Seung Yang; Cheol-Heui Yun; Seung Hyun Han
Journal:  J Microbiol       Date:  2017-12-07       Impact factor: 3.422

5.  Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar.

Authors:  Christian Schaetti; Mitchell G Weiss; Said M Ali; Claire-Lise Chaignat; Ahmed M Khatib; Rita Reyburn; Radboud J Duintjer Tebbens; Raymond Hutubessy
Journal:  PLoS Negl Trop Dis       Date:  2012-10-04

6.  Use of oral cholera vaccines in an outbreak in Vietnam: a case control study.

Authors:  Dang Duc Anh; Anna Lena Lopez; Vu Dinh Thiem; Shannon L Grahek; Tran Nhu Duong; Jin Kyung Park; Hye Jung Kwon; Michael Favorov; Nguyen Tran Hien; John D Clemens
Journal:  PLoS Negl Trop Dis       Date:  2011-01-25

Review 7.  Meeting cholera's challenge to Haiti and the world: a joint statement on cholera prevention and care.

Authors:  Paul Farmer; Charles Patrick Almazor; Emily T Bahnsen; Donna Barry; Junior Bazile; Barry R Bloom; Niranjan Bose; Thomas Brewer; Stephen B Calderwood; John D Clemens; Alejandro Cravioto; Eddy Eustache; Gregory Jérôme; Neha Gupta; Jason B Harris; Howard H Hiatt; Cassia Holstein; Peter J Hotez; Louise C Ivers; Vanessa B Kerry; Serena P Koenig; Regina C Larocque; Fernet Léandre; Wesler Lambert; Evan Lyon; John J Mekalanos; Joia S Mukherjee; Cate Oswald; Jean-William Pape; Anany Gretchko Prosper; Regina Rabinovich; Maxi Raymonville; Jean-Renold Réjouit; Laurence J Ronan; Mark L Rosenberg; Edward T Ryan; Jeffrey D Sachs; David A Sack; Claude Surena; Arjun A Suri; Ralph Ternier; Matthew K Waldor; David Walton; Jonathan L Weigel
Journal:  PLoS Negl Trop Dis       Date:  2011-05-31

8.  A mass vaccination campaign targeting adults and children to prevent typhoid fever in Hechi; expanding the use of Vi polysaccharide vaccine in southeast China: a cluster-randomized trial.

Authors:  Jin Yang; Camilo J Acosta; Guo-ai Si; Jun Zeng; Cui-yun Li; Da-bin Liang; R Leon Ochiai; Anne-Laure Page; M Carolina Danovaro-Holliday; Jie Zhang; Bao-de Zhou; He-zhuang Liao; Ming-liu Wang; Dong-mei Tan; Zhen-zhu Tang; Jian Gong; Jin-kyung Park; Mohammad Ali; Bernard Ivanoff; Gui-chen Liang; Hong-hui Yang; Tikki Pang; Zhi-yi Xu; Allan Donner; Claudia M Galindo; Bai-qing Dong; John D Clemens
Journal:  BMC Public Health       Date:  2005-05-18       Impact factor: 3.295

9.  Improving community coverage of oral cholera mass vaccination campaigns: lessons learned in Zanzibar.

Authors:  Christian Schaetti; Said M Ali; Claire-Lise Chaignat; Ahmed M Khatib; Raymond Hutubessy; Mitchell G Weiss
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

10.  Temporal trends and climatic factors associated with bacterial enteric diseases in Vietnam, 1991-2001.

Authors:  Louise A Kelly-Hope; Wladimir J Alonso; Vu Dinh Thiem; Do Gia Canh; Dang Duc Anh; Hyejon Lee; Mark A Miller
Journal:  Environ Health Perspect       Date:  2008-01       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.